Krystal Biotech (KRYS) Return on Equity [ROE] (2017 - 2026)
Krystal Biotech's Return on Equity [ROE] came in at 16.11% for Q3 2026, down 2.15 percentage points from 18.26% a year earlier and down 2.21 percentage points from the prior quarter.
Powered by 
Analysis
Krystal Biotech (KRYS) Return on Equity [ROE] (2017 - 2026) Analysis & Trends
For FY2025, Krystal Biotech's Return on Equity [ROE] was 18.91%, up 8.58 percentage points from FY2024.
- Return on Equity [ROE] has increased in each of the last three years, with a five-year change of +32.25 percentage points (FY2020 to FY2025).
- Going back by year, Return on Equity [ROE] was 10.34% in FY2024 (+8.66 pp), 1.68% in FY2023 (+26.77 pp), -25.09% in FY2022 (-9.38 pp) and -15.71% in FY2021 (-2.38 pp).
- The Q3 2026 figure represents the lowest quarterly Return on Equity [ROE] since Q2 2025.
- Year-over-year, Return on Equity [ROE] increased in seven of the last eight quarters, with an average year-over-year change of +5.33 percentage points.
- The fastest year-over-year change in Return on Equity [ROE] over five years came in Q2 2024 (a gain of 38.88 percentage points), and the weakest in Q4 2022 (a drop of 13.39 percentage points).
- Business Quant data shows KRYS's Return on Equity [ROE] at 18.32% (Q2 2026), 18.03% (Q1 2026) and 17.37% (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | Krystal Biotech | 9.08 Bn | 5.67 Bn | 119.79 Mn | 15.37% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 15.37% |
| Jun 30, 2026 | 17.90% |
| Mar 31, 2026 | 17.87% |
| Dec 31, 2025 | 17.49% |
| Sep 30, 2025 | 18.22% |
| Jun 30, 2025 | 14.67% |
| Mar 31, 2025 | 12.91% |
| Dec 31, 2024 | 9.64% |
| Sep 30, 2024 | 6.29% |
| Jun 30, 2024 | 12.89% |
| Mar 31, 2024 | 7.23% |
| Dec 31, 2023 | 1.60% |
| Sep 30, 2023 | -4.08% |
| Jun 30, 2023 | -24.35% |
| Mar 31, 2023 | -26.54% |
| Dec 31, 2022 | -26.44% |
| Sep 30, 2022 | -23.85% |
| Jun 30, 2022 | -21.12% |
| Mar 31, 2022 | -18.37% |
| Dec 31, 2021 | -13.92% |
API Access
Krystal Biotech Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=KRYS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "KRYS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=KRYS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();